Effectiveness of Botulinum Toxin Infiltration for treatment of upper limb dysfunctions after treatment for breast cancer.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON26807

Enrollment

Registered

2015-01-07

Start date

2015-02-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients treated for breast cancer and chronic pain (> 3 months) at the breast region

Interventions

- botulinum toxine (experimental group) /saline solution infiltration (control group) at baseline - at baseline start of 3 months of individual physical therapy programme (1x/week) (mobilisations, str

Eligibility

Inclusion criteria

Inclusion criteria: - women after breast cancer with unilateral axillary lymph node dissection or sentinel node biopsy; mastectomy (with or without autologous reconstruction) or wide excision of the tumour - adjuvant chemotherapy and/or radiotherapy finished for at least 3 months - Pain at the breast region for at least 3 months

Exclusion criteria

Exclusion criteria: - Patients with metastasis and patients who cannot participate during the entire study or patients who are mentally or physically not able to participate in the study are excluded - Cases were no injection is possible in the pectoral muscle (e.g. reconstruction with a tissue expander) are excluded as well.

Design outcomes

Secondary

Measure	Time frame
- Pain-pressure thresholds of the pectoral muscles and shoulder girdle muscles - Shoulder mobility - Shoulder function - Shoulder alignment - Quality of life	—

Primary

Measure	Time frame
The primary outcome is the evolution of pain at the breast region.	—

Contacts

Public ContactAn De Groef

UZ Leuven - Dienst Fysische Geneeskunde

an.degroef@kuleuven.be+32 16 34 21 71

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)